KLIMATCHEVA, EKATERINA,PARIS, MARK,SMITH, ERNEST S.
申请号：
EP11822655
公开号：
EP2611832A4
申请日:
2011.09.01
申请国别(地区):
EP
年份:
2014
代理人:
摘要：
Compositions and methods are provided for treating diseases associated with CXCL13 expression, including certain autoimmune diseases, inflammatory diseases, and cancers. In particular, anti-CXCL13 monoclonal antibodies have been developed to neutralize CXCL13.
